• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

    4.250 +0.360 (+9.25%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,668,543
    Open 4.000
    Bid (Size) 4.190 (10)
    Ask (Size) 4.250 (173)
    Prev. Close 3.890
    Today's Range 3.830 - 4.260
    52wk Range 3.830 - 29.30
    Shares Outstanding 92,200,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 of Wall Street’s Favorite Stocks in Dangerous Territory
    Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
    Via StockStory
    Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay & Murray LLP
    Via Business Wire

    Performance

    YTD
    -68.5%
    -68.5%
    1 Month
    -47.4%
    -47.4%
    3 Month
    -65.9%
    -65.9%
    6 Month
    -75.4%
    -75.4%
    1 Year
    -83.0%
    -83.0%

    More News

    Read More
    Myriad Genetics, Inc. (MYGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    Earnings Scheduled For May 6, 2025
    Via Benzinga
    Myriad Genetics's Earnings: A Preview
    Via Benzinga
    Myriad Genetics Shares Tank 41% On Analyst Downgrades, Weaker Guidance: Yet Retail Investors Remain Bullish
    Via Stocktwits
    Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    What Analysts Are Saying About Myriad Genetics Stock
    Via Benzinga
    Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    Top movers in Wednesday's session
    Via Chartmill
    Why Myriad Genetics (MYGN) Stock Is Down Today
    Via StockStory
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Crude Oil Falls 1%; Uber Sales Miss Estimates
    Via Benzinga
    Topics Earnings
    Exposures Financial Fossil Fuels
    Wednesday's session: top gainers and losers
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session.
    Via Chartmill
    These stocks that are showing activity before the opening bell on Wednesday.
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Myriad Genetics (NASDAQ:MYGN) Misses Q1 Sales Targets, Stock Drops 14.5%
    Via StockStory
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Which stocks are moving after the closing bell on Tuesday?
    Via Chartmill
    Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    What To Expect From Myriad Genetics’s (MYGN) Q1 Earnings
    Via StockStory
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    3 Unprofitable Stocks Walking a Fine Line
    Via StockStory
    1 Unprofitable Stock to Target This Week and 2 to Be Wary Of
    Via StockStory
    Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor
    From Myriad Genetics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Myriad Genetics, Inc. - Common Stock publicly traded?
    Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
    What exchange does Myriad Genetics, Inc. - Common Stock trade on?
    Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
    The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
    What is the current price of Myriad Genetics, Inc. - Common Stock?
    The current price of Myriad Genetics, Inc. - Common Stock is 4.250
    When was Myriad Genetics, Inc. - Common Stock last traded?
    The last trade of Myriad Genetics, Inc. - Common Stock was at 05/12/25 04:00 PM ET
    What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
    The market capitalization of Myriad Genetics, Inc. - Common Stock is 391.85M
    How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
    Myriad Genetics, Inc. - Common Stock has 392M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.